Article Details
Retrieved on: 2021-05-10 15:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Dive Brief: Amgen on Monday said it has submitted for Food and Drug Administration approval its asthma drug hopeful tezepelumab, advancing a ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here